STOCK TITAN

Strata Critical Medical (SRTA) awards 44,438 RSUs to board director

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cook William L. III reported acquisition or exercise transactions in this Form 4 filing.

Strata Critical Medical, Inc. reported that director William L. Cook III received a grant of 44,438 Restricted Stock Units (RSUs) on July 30, 2026. The RSUs, granted at $0.0000 per share, will settle in Class A common stock when vested, with 100% vesting on the date of the company’s 2027 Annual Meeting of Stockholders. Following this award, Cook directly holds 97,671 shares of Class A common stock.

Positive

  • None.

Negative

  • None.
Insider Cook William L. III
Role Director
Type Security Shares Price Value
Grant/Award Class A common stock, $0.0001 par value per share F1 44,438 $0.00 $0.00
Holdings After Transaction: Class A common stock, $0.0001 par value per share — 97,671 shares (Direct)
Footnotes (1)
  1. F1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.
RSUs granted 44,438 shares Restricted Stock Units granted to William L. Cook III on July 30, 2026
Award price per share $0.0000 Grant price per share for the RSU award
Holdings after transaction 97,671 shares Class A common stock directly owned after the RSU grant
Par value per share $0.0001 Par value of Class A common stock underlying the RSUs
Restricted Stock Units financial
"Represents a grant of Restricted Stock Units ("RSUs"), which will"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
vested financial
"100% of the RSUs will become vested on the date of the"
par value financial
"Class A common stock, $0.0001 par value per share"
Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Strata Critical Medical (SRTA) report for William L. Cook III?

Strata Critical Medical reported that director William L. Cook III received a grant of 44,438 Restricted Stock Units on July 30, 2026. These RSUs are equity compensation that will convert into Class A common shares when they vest.

When do the 44,438 RSUs granted by Strata Critical Medical (SRTA) vest?

All 44,438 RSUs granted to William L. Cook III vest 100% on the date of Strata Critical Medical’s 2027 Annual Meeting of Stockholders. At that time, they will be settled in shares of Class A common stock.

How many Strata Critical Medical (SRTA) shares does William L. Cook III own after this Form 4 transaction?

After the RSU grant, William L. Cook III directly holds 97,671 shares of Strata Critical Medical’s Class A common stock. This figure reflects his direct ownership immediately following the July 30, 2026 award.

Was the Strata Critical Medical (SRTA) RSU grant a market purchase or sale?

The RSU grant was not a market purchase or sale. It is a compensation award coded as an acquisition, granted at $0.0000 per share, and will convert into shares upon vesting rather than being bought or sold in the market.

Are the Strata Critical Medical (SRTA) RSUs granted to William L. Cook III covered by a Rule 10b5-1 plan?

The filing’s Rule 10b5-1 checkbox is not checked, indicating the RSU grant was not reported as made under a Rule 10b5-1 trading plan. It is disclosed as a standard equity compensation award to a director.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cook William L. III

(Last)(First)(Middle)
C/O STRATA CRITICAL MEDICAL, INC.
666 THIRD AVENUE, 25TH FLOOR

(Street)
NEW YORK NEW YORK 10017

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Strata Critical Medical, Inc. [ SRTA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
07/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A common stock, $0.0001 par value per share07/30/2026A44,438(1)A$097,671D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a grant of Restricted Stock Units ("RSUs"), which will be settled in shares of the Issuer's common stock upon vesting. 100% of the RSUs will become vested on the date of the Issuer's 2027 Annual Meeting of Stockholders.
Remarks:
/s/ Melissa M. Tomkiel, Attorney-in-fact for William L. Cook, III08/03/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)